4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Odyssey Therapeutics, Inc. (ODTX) operates in the Biotechnology industry and is headquartered in Boston, United States with about 100 employees. Its market capitalization is roughly $808 million. In the fiscal year ended 2025-12-31, ODTX reported $3M in revenue and ($149M) in net income.
Odyssey Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines for autoimmune and inflammatory diseases.
Interactive charts & full statements → Open the ODTX valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $3M | $4M | $1M | $0M |
| Operating Income (EBIT) | ($161M) | ($135M) | ($133M) | ($123M) |
| Net Income | ($149M) | ($129M) | ($126M) | ($125M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|
| Total Revenue | $0M | $2M | $2M |
| Operating Income (EBIT) | ($40M) | ($45M) | ($37M) |
| Net Income | ($38M) | ($38M) | ($36M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Assets | $270M | $197M | $286M | $317M |
| Total Liabilities | $758M | $580M | $549M | $462M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ODTX viewer.
About TickerBase · Data methodology & sources